NO20064295L - Bruk av metylenamidderivater i kardiovaskulaere lidelser - Google Patents

Bruk av metylenamidderivater i kardiovaskulaere lidelser

Info

Publication number
NO20064295L
NO20064295L NO20064295A NO20064295A NO20064295L NO 20064295 L NO20064295 L NO 20064295L NO 20064295 A NO20064295 A NO 20064295A NO 20064295 A NO20064295 A NO 20064295A NO 20064295 L NO20064295 L NO 20064295L
Authority
NO
Norway
Prior art keywords
cardiovascular disorders
derivatives
methylenamide
prevention
formula
Prior art date
Application number
NO20064295A
Other languages
English (en)
Inventor
Rob Hooft Van Huijsduijnen
Vincent Richard
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20064295L publication Critical patent/NO20064295L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Den foreliggende oppfinnelsen gjelder anvendelsen av substituerte metylenamidderivater med formel (I) for behandling og/eller forebygging av kardiovaskulære lidelser som koronar obstruksjon og hjertesvikt. Spesielt gjelder den foreliggende oppfinnelsen anvendelsen av substituerte metylenamidderivater med formel (I) spesielt for behandling og/eller forebygging av endotelisk dysfunksjon ved hjertesvikt.
NO20064295A 2004-02-27 2006-09-22 Bruk av metylenamidderivater i kardiovaskulaere lidelser NO20064295L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04100778 2004-02-27
PCT/EP2005/050823 WO2005082347A1 (en) 2004-02-27 2005-02-25 Use of methylene amide derivatives in cardiovascular disorders

Publications (1)

Publication Number Publication Date
NO20064295L true NO20064295L (no) 2006-09-22

Family

ID=34896106

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064295A NO20064295L (no) 2004-02-27 2006-09-22 Bruk av metylenamidderivater i kardiovaskulaere lidelser

Country Status (24)

Country Link
US (1) US20070185118A1 (no)
EP (1) EP1732534B1 (no)
JP (1) JP5001138B2 (no)
KR (1) KR101188940B1 (no)
CN (1) CN1933827B (no)
AT (1) ATE401877T1 (no)
AU (1) AU2005216649B2 (no)
BR (1) BRPI0508080A (no)
CA (1) CA2554919C (no)
CY (1) CY1108252T1 (no)
DE (1) DE602005008412D1 (no)
DK (1) DK1732534T3 (no)
EA (1) EA011811B1 (no)
ES (1) ES2308458T3 (no)
HK (1) HK1098073A1 (no)
HR (1) HRP20080367T3 (no)
IL (1) IL177494A (no)
NO (1) NO20064295L (no)
PL (1) PL1732534T3 (no)
PT (1) PT1732534E (no)
RS (1) RS50596B (no)
SI (1) SI1732534T1 (no)
UA (1) UA84453C2 (no)
WO (1) WO2005082347A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE510817T1 (de) * 2002-01-29 2011-06-15 Merck Serono Sa Substituierte methylenamidderivate als modulatoren von proteintyrosinphosphatasen (ptps)
ES2337150T3 (es) 2003-07-21 2010-04-21 Merck Serono Sa Alquinilaril carboxamidas.
WO2008044731A1 (fr) 2006-10-12 2008-04-17 Institute Of Medicinal Molecular Design. Inc. Dérivé d'acide n-phényloxamidique
US8633245B2 (en) * 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
US8906258B2 (en) 2011-08-29 2014-12-09 Ticona Llc Heat-resistant liquid crystalline polymer composition having a low melting temperature
US9045685B2 (en) 2011-08-29 2015-06-02 Ticona Llc Cast molded parts formed from a liquid crystalline polymer
KR20140057629A (ko) 2011-08-29 2014-05-13 티코나 엘엘씨 방향족 아마이드 화합물
WO2013032975A1 (en) 2011-08-29 2013-03-07 Ticona Llc Thermotropic liquid crystalline polymer with improved low shear viscosity
TW201313884A (zh) 2011-08-29 2013-04-01 Ticona Llc 液晶聚合物之固態聚合
US8852730B2 (en) 2011-08-29 2014-10-07 Ticona Llc Melt-extruded substrate for use in thermoformed articles
WO2013032981A1 (en) 2011-08-29 2013-03-07 Ticona Llc High flow liquid crystalline polymer composition
JP2014525500A (ja) 2011-08-29 2014-09-29 ティコナ・エルエルシー 低溶融粘度液晶ポリマーの溶融重合
TW201319223A (zh) 2011-08-29 2013-05-16 Ticona Llc 高流量液晶聚合物組合物
WO2014095815A1 (en) 2012-12-17 2014-06-26 Shell Internationale Research Maatschappij B.V. Integrated gas-to-liquid condensate process
WO2014130275A2 (en) 2013-02-22 2014-08-28 Ticona Llc High performance polymer composition with improved flow properties
US9206300B2 (en) 2013-06-07 2015-12-08 Ticona Llc High strength thermotropic liquid crystalline polymer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6985200A (en) * 1999-09-10 2001-04-17 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
US6627767B2 (en) * 2000-08-29 2003-09-30 Abbott Laboratories Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors
DE10117823A1 (de) * 2001-04-10 2002-10-17 Merck Patent Gmbh Oxalsäurederivate
WO2002098408A1 (en) * 2001-06-07 2002-12-12 Wyeth Ptpase inhibitors for improving cardiovascular risk profile
AR034374A1 (es) * 2001-06-07 2004-02-18 Wyeth Corp Combinacion de un inhibidor de ptpasa y un inhibidor de ace
ATE510817T1 (de) * 2002-01-29 2011-06-15 Merck Serono Sa Substituierte methylenamidderivate als modulatoren von proteintyrosinphosphatasen (ptps)

Also Published As

Publication number Publication date
CN1933827A (zh) 2007-03-21
EP1732534A1 (en) 2006-12-20
CA2554919A1 (en) 2005-09-09
UA84453C2 (ru) 2008-10-27
PL1732534T3 (pl) 2008-12-31
JP2007524701A (ja) 2007-08-30
KR20060129066A (ko) 2006-12-14
EP1732534B1 (en) 2008-07-23
DE602005008412D1 (de) 2008-09-04
ATE401877T1 (de) 2008-08-15
WO2005082347A1 (en) 2005-09-09
BRPI0508080A (pt) 2007-07-17
PT1732534E (pt) 2008-08-08
IL177494A0 (en) 2006-12-31
EA200601511A1 (ru) 2007-02-27
CA2554919C (en) 2013-04-16
JP5001138B2 (ja) 2012-08-15
RS50596B (sr) 2010-05-07
HRP20080367T3 (en) 2008-09-30
AU2005216649A1 (en) 2005-09-09
DK1732534T3 (da) 2008-11-17
EA011811B1 (ru) 2009-06-30
AU2005216649B2 (en) 2010-09-09
US20070185118A1 (en) 2007-08-09
ES2308458T3 (es) 2008-12-01
IL177494A (en) 2011-06-30
HK1098073A1 (en) 2007-07-13
SI1732534T1 (sl) 2008-10-31
CY1108252T1 (el) 2014-02-12
CN1933827B (zh) 2011-07-27
KR101188940B1 (ko) 2012-10-08

Similar Documents

Publication Publication Date Title
NO20064295L (no) Bruk av metylenamidderivater i kardiovaskulaere lidelser
NO20071343L (no) Substituerte fenylaminotiazoler og anvendelse derav
NO20070933L (no) Indazoler anvendbare i behandling av kardiovaskulaere sykdommer
NO20062561L (no) Kinoliner nyttige for behandling av kardiovaskulaere sykdommer
ATE453393T1 (de) Verwendung von pyridylamiden als angiogenesehemmer
EA200870019A1 (ru) Лактамовые соединения и способы их применения
ATE371656T1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
ATE551059T1 (de) Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie
MY140903A (en) Imidazole derivatives used as tafia inhibitors
DE602004022668D1 (de) 5-gliedrige heterocyclische p-38 inhibitoren
MX2009010960A (es) Compuestos heterociclicos y sus metodos de uso.
WO2007114848A3 (en) Chemical compounds
ATE505191T1 (de) Ectoin zur behandlung von vascular leaks
ATE331709T1 (de) Substituierte 3-carbonyl-1-yl essigsäure derivate als plasminogen aktivator inhibitor(pai-1) inhibitoren
MA33915B1 (fr) Nouveaux derives d' (heterocycle-piperidine condensee)-(piperazinyl)-1-alcanone ou d' (heterocycle-pyrrolidine condensee)-(piperazinyl)-1-alcanone et leur utilisation comme inhibiteurs de p75
TW200736264A (en) Thiazolo[4,5-C]pyridine derivatives
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
EA200602083A1 (ru) Новые пиперазиновые производные диалкилоксиндолов
EA200602084A1 (ru) Пиперазиновые производные алкилоксиндолов
NO20073610L (no) Nye substituerte tiofenpyrimidinonderivater som inhibitorer for 17 β-hydroksysteroiddehydrogenase
DE602004010186D1 (de) Diazaspiropiperidinderivate als inhibitoren von glycintransporter 1 und glycintransporter 2
EA200602082A1 (ru) Производные индол-2-она для лечения расстройств центральной нервной системы, желудочно-кишечных расстройств и сердечно-сосудистых расстройств
ATE412634T1 (de) Piperazinderivate von alkyloxindolen
MX2007004535A (es) Antagonistas de integrinas bifenilicos.

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application